Recall D-0116-2026

US Class II Ongoing · initiated 2025-10-15

Recalling firm

ProRx LLC, PA

Product

Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-08

Reason for recall

Lack of Assurance of Sterility

← All recalls